| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2005PNAS..10213301G |
| P356 | DOI | 10.1073/PNAS.0506034102 |
| P932 | PMC publication ID | 1201605 |
| P698 | PubMed publication ID | 16131546 |
| P5875 | ResearchGate publication ID | 7628519 |
| P2093 | author name string | Vadim Y Bolshakov | |
| Francine M Benes | |||
| Barbara Gisabella | |||
| P2860 | cites work | A functional neuroanatomy of hallucinations in schizophrenia | Q28283938 |
| Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory | Q30500328 | ||
| Neuroimaging studies of the hippocampus in schizophrenia | Q30666577 | ||
| Cholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus. | Q31813473 | ||
| Amygdalar activation alters the hippocampal GABA system: "partial" modelling for postmortem changes in schizophrenia | Q31912055 | ||
| Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies | Q32082435 | ||
| Pieces of the schizophrenia puzzle fall into place | Q33367610 | ||
| Pharmacologic treatment of schizophrenia. | Q33782631 | ||
| Hereditary vascular dementia linked to notch 3 mutations. CADASIL in British families | Q33922717 | ||
| GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder | Q33948632 | ||
| Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia | Q33981274 | ||
| Modulation of hippocampal long-term potentiation by the amygdala: a synaptic mechanism linking emotion and memory | Q34295688 | ||
| Emotion, cognition, and behavior | Q34992922 | ||
| Medicine. What are the right targets for psychopharmacology? | Q35047348 | ||
| Muscarinic receptors in schizophrenia. | Q35207350 | ||
| Muscarinic mechanisms of antipsychotic atypicality | Q35595252 | ||
| Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention? | Q35679592 | ||
| A GABAergic cortical deficit dominates schizophrenia pathophysiology | Q35974076 | ||
| GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. | Q36112064 | ||
| Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells | Q36311933 | ||
| Amygdala stimulation modulates hippocampal synaptic plasticity | Q37557532 | ||
| Muscarinic receptor subtypes and the selectivity of agonists and antagonists | Q38199713 | ||
| Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus | Q38340649 | ||
| Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia | Q41199819 | ||
| Cholinergic Activity Enhances Hippocampal Long-Term Potentiation in CA1 during Walking in Rats | Q42451462 | ||
| Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies | Q42473922 | ||
| Reinforcement of early long-term potentiation (early-LTP) in dentate gyrus by stimulation of the basolateral amygdala: heterosynaptic induction mechanisms of late-LTP. | Q43594268 | ||
| Amygdala is critical for stress-induced modulation of hippocampal long-term potentiation and learning. | Q43662845 | ||
| The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects | Q43744085 | ||
| Cholinergic modulation of synaptic physiology in deep layer entorhinal cortex of the rat. | Q43765177 | ||
| Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia | Q44014143 | ||
| Mechanisms of amygdala modulation of hippocampal plasticity. | Q44213509 | ||
| Selective muscarinic regulation of functional glutamatergic Schaffer collateral synapses in rat CA1 pyramidal neurons. | Q44218013 | ||
| Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice | Q44250012 | ||
| Association of muscarinic m1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients | Q44592905 | ||
| Glutamate uptake determines pathway specificity of long-term potentiation in the neural circuitry of fear conditioning. | Q44722222 | ||
| Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death | Q44790267 | ||
| A description of the amygdalo-hippocampal interconnections in the macaque monkey | Q44882902 | ||
| Long-term effects of amygdala GABA receptor blockade on specific subpopulations of hippocampal interneurons | Q45070193 | ||
| Encoding of emotional memories depends on amygdala and hippocampus and their interactions | Q47221902 | ||
| Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain | Q47856910 | ||
| Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders | Q48105018 | ||
| Exposing rats to a predator blocks primed burst potentiation in the hippocampus in vitro | Q48162563 | ||
| Impaired recruitment of the hippocampus during conscious recollection in schizophrenia | Q48242681 | ||
| Potential role of muscarinic receptors in schizophrenia | Q48268803 | ||
| Projections from the amygdaloid complex and adjacent olfactory structures to the entorhinal cortex and to the subiculum in the rat and cat | Q48299587 | ||
| Excitatory effects of muscarine on septohippocampal neurons: involvement of M3 receptors | Q48397074 | ||
| The basomedial and basolateral amygdaloid nuclei contribute to the induction of long-term potentiation in the dentate gyrus in vivo | Q48923874 | ||
| Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain | Q49018822 | ||
| Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain | Q49019867 | ||
| Should allosteric positive modulators of GABA(A) receptors be tested in the treatment of schizophrenia? | Q49143296 | ||
| Cholinergic excitation of septohippocampal GABA but not cholinergic neurons: implications for learning and memory. | Q51402433 | ||
| Biphasic modulation of hippocampal plasticity by behavioral stress and basolateral amygdala stimulation in the rat. | Q52030861 | ||
| Muscarinic tone sustains impulse flow in the septohippocampal GABA but not cholinergic pathway: implications for learning and memory. | Q52541349 | ||
| Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation | Q72240898 | ||
| Emerging principles of altered neural circuitry in schizophrenia | Q73553170 | ||
| Cholinergic modulation of synaptic transmission and plasticity in entorhinal cortex and hippocampus of the rat | Q73862989 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| synaptic plasticity | Q1551556 | ||
| P304 | page(s) | 13301-13306 | |
| P577 | publication date | 2005-08-30 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Regulation of synaptic plasticity in a schizophrenia model | |
| P478 | volume | 102 |
| Q48218870 | A rat model for neural circuitry abnormalities in schizophrenia |
| Q48331293 | Acute clozapine suppresses synchronized pyramidal synaptic network activity by increasing inhibition in the ferret prefrontal cortex |
| Q30475524 | Amygdalocortical circuitry in schizophrenia: from circuits to molecules |
| Q36939248 | Brain neuroplasticity in healthy, hyperactive and psychotic children: insights from neuroimaging |
| Q42154902 | Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia |
| Q24676534 | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis |
| Q24646206 | Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia |
| Q30453671 | Conscious experience and episodic memory: hippocampus at the crossroads |
| Q44279148 | Effects of antipsychotic drugs on the expression of synaptic proteins and dendritic outgrowth in hippocampal neuronal cultures |
| Q36161984 | Epigenetic Regulation of Glutamic Acid Decarboxylase 67 in a Hippocampal Circuit. |
| Q36942576 | Functional magnetic resonance imaging (fMRI) of attention processes in presumed obligate carriers of schizophrenia: preliminary findings |
| Q33996803 | Glutamate and schizophrenia: beyond the dopamine hypothesis |
| Q34187208 | Kainate receptor-mediated modulation of hippocampal fast spiking interneurons in a rat model of schizophrenia |
| Q38566255 | Long-term potentiation (LTP) of human sensory-evoked potentials |
| Q36852122 | Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex |
| Q28285118 | Psychosis and autism as diametrical disorders of the social brain |
| Q36686912 | Rat modeling for GABA defects in schizophrenia |
| Q33271010 | Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. |
| Q48377798 | The amygdala modulates neuronal activation in the hippocampus in response to spatial novelty |
| Q36633604 | The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions |
| Q30487850 | The evolution of drug development in schizophrenia: past issues and future opportunities |
Search more.